Details for 2014703426
Up to date per 03.04.2026
Actions
Details for 2014703426
Deleted
European Patent
25.11.2015 A
30.06.2021 B1
15.01.2013
US
201361752772 P
A61K 31/501 20060101AFI20201216BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
No representatives present
Inventor
FENDT, MarkusNovartis Pharma AG Postfach CH-4002 BaselCH
FEUERBACH, DominikNovartis Pharma AG Postfach CH-4002 BaselCH
FINNEMA, Sjoerd JohannesKarolinska Institutet Departement of Clinical Neuroscience Psychiatry Section Karolinska University Hospital Solna R5:02 S-171 76 StockholmSE
HALLDIN, ChristerKarolinska Institutet Departement of Clinical Neuroscience Psychiatry Section Karolinska University Hospital Solna R5:02 S-171 76 StockholmSE
JOHNS, DonaldNovartis Institutes for BioMedical Research Inc. 220 Massachusetts Avenue Cambridge, Massachusetts 02139US
LOPEZ-LOPEZ, CristinaNovartis Pharma AG Postfach CH-4002 BaselCH
MCALLISTER, Kevin HallNovartis Pharma AG Postfach CH-4002 BaselCH
SOVAGO, JuditNovartis Pharma AG Postfach CH-4002 BaselCH
WEISS, MarkusNovartis Pharma AG Postfach CH-4002 BaselCH